The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis

被引：0
|
作者：
Huy Gia Vuong
Thu Quynh Nguyen
Tam N. M. Ngo
Hoang Cong Nguyen
Kar-Ming Fung
Ian F. Dunn
机构：
[1] Oklahoma University Health Sciences Center,Department of Pathology
[2] Oklahoma University Health Sciences Center,Stephenson Cancer Center
[3] Pham Ngoc Thach University of Medicine,Faculty of Medicine
[4] Oklahoma University Health Sciences Center,Department of Neurosurgery
来源：
BMC Cancer | / 20卷
关键词：
Glioma; Glioblastoma; TERT; MGMT; Temozolomide; Overall survival; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Characterizing benefit from temozolomide in MGMT promoter unmethylated and methylated glioblastoma: a systematic review and meta-analysis
    Alnahhas, Iyad
    Alsawas, Mouaz
    Rayi, Appaji
    Palmer, Joshua D.
    Raval, Raju
    Ong, Shirley
    Giglio, Pierre
    Murad, Mohammad Hassan
    Puduvalli, Vinay
    NEURO-ONCOLOGY ADVANCES, 2020, 2 (01)
  • [42] TERT promoter mutations and melanoma survival: A comprehensive literature review and meta-analysis
    Gandini, Sara
    Zanna, Ines
    De Angelis, Simone
    Palli, Domenico
    Raimondi, Sara
    Ribero, Simone
    Masala, Giovanna
    Suppa, Mariano
    Bellerba, Federica
    Corso, Federica
    Nezi, Luigi
    Nagore, Eduardo
    Caini, Saverio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 160
  • [43] BRAF Mutation is Associated with an Improved Survival in Glioma—a Systematic Review and Meta-analysis
    Huy Gia Vuong
    Ahmed M. A. Altibi
    Uyen N. P. Duong
    Hanh T. T. Ngo
    Thong Quang Pham
    Kar-Ming Fung
    Lewis Hassell
    Molecular Neurobiology, 2018, 55 : 3718 - 3724
  • [44] Association between promoter methylation of DAPK lgene and HNSCC: A meta-analysis
    Cai, Fucheng
    Xiao, Xiyue
    Niu, Xun
    Zhong, Yi
    PLOS ONE, 2017, 12 (03):
  • [45] Meta-analysis of the association between APC promoter methylation and colorectal cancer
    Ding, Zhenyu
    Jiang, Tong
    Piao, Ying
    Han, Tao
    Han, Yaling
    Xie, Xiaodong
    ONCOTARGETS AND THERAPY, 2015, 8 : 211 - 222
  • [46] The value of MGMT promote methylation and IDH-1 mutation on diagnosis of pseudoprogression in patients with high-grade glioma A meta-analysis
    Zhou, Min
    Niu, Chaoshi
    Jia, Li
    He, Hu
    MEDICINE, 2019, 98 (50)
  • [47] MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta-analysis
    Chen, Bizheng
    Ying, Xiaozhen
    Bao, Liming
    THORACIC CANCER, 2021, 12 (23) : 3194 - 3200
  • [48] BRAF Mutation is Associated with an Improved Survival in Glioma-a Systematic Review and Meta-analysis
    Huy Gia Vuong
    Altibi, Ahmed M. A.
    Duong, Uyen N. P.
    Ngo, Hanh T. T.
    Thong Quang Pham
    Fung, Kar-Ming
    Hassell, Lewis
    MOLECULAR NEUROBIOLOGY, 2018, 55 (05) : 3718 - 3724
  • [49] Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients
    Yuan, Guoqiang
    Niu, Liang
    Zhang, Yinian
    Wang, Xiaoqing
    Ma, Kejun
    Yin, Hang
    Dai, Junqiang
    Zhou, Wangning
    Pan, Yawen
    JOURNAL OF NEURO-ONCOLOGY, 2017, 133 (01) : 193 - 201
  • [50] The association between RAR and FHIT promoter methylation and the carcinogenesis of patients with cervical carcinoma: A meta-analysis
    Shu, Ruming
    He, Jie
    Wu, Chengzhen
    Gao, Jun
    TUMOR BIOLOGY, 2017, 39 (06)
12345